Tuesday, March 11, 2025

Technology

NurExone Biologic Advances Glaucoma Research with Cutting-Edge Exosome-Based Therapies (TSXV: NRX, OTCQB: NRXBF)

TORONTO and HAIFA, Israel, June 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a...

NurExone Biologic Inc. Accelerates Growth with Dr. Yona Geffen’s Expertise (TSXV: NRX, OTCQB: NRXBF)

NurExone Biologic Inc TORONTO and HAIFA, Israel, June 21, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90 is a pioneering...

RenovoRx’s TAMP Platform Revolutionizes Cancer Therapy (Nasdaq: RNXT)

 ("RenovoRx" or the "Company") (Nasdaq: RNXT), is a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform.  Recently, the Company announced the...

The Rise and Future of Cyber Security Stocks: Investing in a Secure Digital World

The cyber security sector is expanding rapidly due to an increase in cyber threats and the need for advanced protection technologies. This continuous demand...

The Potential of AI to Supercharge the U.S. Economy

AI's ability to automate tasks and drive productivity gains presents a transformative force for the economy, promising revolutionary changes across various sectors. Predictions suggest that...

Popular

Subscribe